Source link : https://www.newshealth.biz/health-news/arthritis-patients-more-likely-to-stick-with-biosimilars/
Spanish patients with various forms of inflammatory arthritis who started either etanercept or adalimumab were more likely to continue taking them if they were biosimilar versions rather than the originator product, researchers found. Discontinuation rates over 2 to 3 years of follow-up were 53.3% for originator products versus 33.4% for biosimilars, according to María Paz […]
Author : News Health
Publish date : 2024-09-03 17:55:54
Copyright for syndicated content belongs to the linked Source.